Cue Biopharma, Inc. — Director's Dealing 2021

Oct 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cue Biopharma, Inc. (CUE)
CIK: 0001645460
Period of Report: 2021-09-30

Reporting Person: PASSERI DANIEL R (Director, CHIEF EXECUTIVE OFFICER)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-30	Common Stock	M	75000	—	Acquired	130377	Direct
2021-09-30	Common Stock	F	31677	$14.57	Disposed	98700	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-30	Restricted Stock Units	$	M	75000	Disposed		Common Stock (75000)	Direct

Footnotes

F1: Represents shares of common stock received upon vesting of a restricted stock unit award.

F2: Each restricted stock unit award represents a contingent right to receive one share of common stock.

F3: One half of the Restricted Stock Units vested on September 30, 2021 and the balance will vest on March 31, 2022.